Support for patients
This site is designed to provide information to patients who have been prescribed an Amgen® medicine. Should you have any concerns or questions regarding your treatment, please speak to your doctor or nurse.
Please select one of the options below:
I am, or I care for, an AMGEVITA®▼ (adalimumab) patient.
I am, or I care for, a Repatha® (evolocumab) patient.
I am, or I care for, a Neulasta® ONPRO® (pegfilgrastim) patient.
I am, or I care for, a Nplate® (romiplostim) patient.
I am, or I care for, a XGEVA® (denosumab) patient.
I am a member of the general public and have not been prescribed any of these Amgen® medicines.
▼ This medicinal product is subject to additional monitoring.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
. Adverse events should also be reported to Amgen Limited on +44 (0) 1223 436441. By reporting side effects, you can help provide more information on the safety of our medicines.
Please report any potential quality issue with the Amgen product you have received, by calling us on +44 (0) 1223 436441 and providing us with the
details. Please ensure that you keep your packaging, so we are able to identify your product more easily.